Track Chair:
Adrian Lee, UPMC

PMWC Award Ceremony
• Dennis J. Slamon, UCLA
• Arul M. Chinnaiyan, University of Michigan

Keynote: Molecular Diversity of Human Malignancies: Diagnostic and Therapeutic Implications
• Dennis J. Slamon, UCLA

Keynote: From Cancer Drivers to Clinical Decisions: Transforming Tumor Genomics
• Arul M. Chinnaiyan, University of Michigan

Serial ctDNA-Guided Therapy Switching (SERENA-6 & Beyond)
• Chair: Adrian Lee, UPMC
• Pedram Razavi, MSK
• Minetta Liu, Natera
• Emre Baser, Astrazeneca
• Christian Rolfo, Ohio State

Neoadjuvant to Adjuvant MRD: How Early Is Early Enough?
• Chair: Angela DeMichele, UPenn
• Halla Nimeiri, Tempus
• Aparna Parikh, Harvard
• Minetta Liu, Natera
• C. Ola Landgren, U Miami
• Christopher Lieu, U Colorado

Rapid MRD to Treatment Decisions: Standardized ctDNA at Scale
• Chair: Luca Quagliata, Thermo Fisher
• Christian Rolfo, Ohio State

Multi-Omics Monitoring Beyond Variants: Methylation, Fragmentomics, EV/ctRNA
• Chair: David T. Miyamoto, Massachusetts General Hospital
• Maximilian Diehn, Stanford
• Daniel De Carvalho, University of Toronto

From Detection to Direction: Whole-Genome MRD for Therapy Guidance at Scale
• Phil Febbo, Veracyte

Precision Engineering: Customizing High-Sensitivity ctDNA Assays for Therapy Guidance at Scale
• Siyuan Chen, Twist Bioscience

From Validation to Payment: Coverage Pathways That Work
• Chair: Mark Stewart, Friends of Cancer Research
• Hilary Gee Goeckner, American Cancer Society (ACS)
• Sally Werner, Cancer Support Community
• Gabriel A. Bien-Willner, Palmetto GBA